EULAR 2026

BRUSSELS, Belgium, May 19, 2026 UCB announced new Phase 3b clinical data showing that BIMZELX® (bimekizumab) demonstrated superior efficacy...

SAN DIEGO, California, May 19, 2026 Artiva Biotherapeutics announced multiple data presentations at the upcoming EULAR 2026 Congress highlighting...